3

FORM 3 SUBMISSION

Company: Eledon Pharmaceuticals, Inc.
Filed: May 28, 2015
Period of Report: May 26, 2015
Accession Number: 0001209191-15-047653

View Document ↗ View on SEC.gov ↗